title: Effect of oral selenium administration on cisplatin-induced nephrotoxicity in rats.
abstract: Cis -diamminedichloroplatinum(II) (CP), an important antineoplasic drug, shows remarkable toxicity to the kidney. Methods to reduce CP nephrotoxicity include the use of sodium selenite. The aim of the present study was to investigate the interaction between orally administered selenium and CP in the rat. After observing the effects of CP on body growth rate, urinary volume, serum creatinine, serum selenium levels, creatinine clearance, renal malondialdehyde, and glutathione levels, as well as on renal light microscopically visible lesions, the effects of the sodium selenite administration by gavage of 2 mg per kg of body wt. 24 h and 1 h prior to a single CP intraperitoneal injection of 5 mg per kg of body wt. followed by its daily administration for the 7 subsequent days on these parameters, were examined. CP increased renal malondialdehyde, renal glutathione, and serum creatinine and decreased creatinine clearance. Lipid peroxidation is one of the mechanisms by which CP induces renal damage. Selenium treatment decreased the effect of CP on serum creatinine, and renal malondialdehyde levels, but did not affect the other parameters with the exception of kidney necrosis which was also diminished by this treatment.
authors.affiliation: Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Universidade de São Paulo, Brasil.
authors.forename: H D
authors.initials: HD
authors.lastname: Francescato
authors.forename: R S
authors.initials: RS
authors.lastname: Costa
authors.forename: S M
authors.initials: SM
authors.lastname: Rodrigues Camargo
authors.forename: M A
authors.initials: MA
authors.lastname: Zanetti
authors.forename: M A
authors.initials: MA
authors.lastname: Lavrador
authors.forename: M D
authors.initials: MD
authors.lastname: Bianchi
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000970:Antineoplastic Agents / Q000037:antagonists & inhibitors / Q000633:toxicity*; D001835:Body Weight / Q000187:drug effects; D002945:Cisplatin / Q000037:antagonists & inhibitors / Q000633:toxicity*; D003404:Creatinine / Q000097:blood; D005978:Glutathione / Q000378:metabolism; D007441:Intubation, Gastrointestinal; D007668:Kidney / Q000187:drug effects* / Q000473:pathology*; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012643:Selenium / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D008315:Malondialdehyde; D003404:Creatinine; D005978:Glutathione; D012643:Selenium; D002945:Cisplatin